Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2025-12-28 @ 2:11 PM
Study NCT ID:
NCT04555304
Status:
UNKNOWN
Last Update Posted:
2020-09-18
First Post:
2020-08-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy
Sponsor:
Chengdu Kanghong Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-01-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-05
First Submit QC Date:
None
Study First Post Date:
2020-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-14
Last Update Post Date:
2020-09-18
Last Update Post Date Type:
ACTUAL